Category: Finance
Class actions have been initiated for stockholders of CVS Health, Walgreens, SeaStar Medical, and Bolt Biotherapeutics due to misleading statements regarding their business operations and financial forecasts. CVS faced significant stock price drops following revisions to its earnings guidance and operational income, primarily due to issues in its Health Care Benefits segment. Walgreens and SeaStar also reported financial challenges, leading to class action notices for investors. Bolt Biotherapeutics is accused of overstating the effectiveness of its product pipeline.
Keywords: CVS Health, Walgreens, SeaStar Medical, Bolt Biotherapeutics, class action
Update At: 8/7/2024